Literature DB >> 9847389

Characterization of a natural mutation in an antigenic site on the fusion protein of measles virus that is involved in neutralization.

J Fayolle1, B Verrier, R Buckland, T F Wild.   

Abstract

Although measles virus is an antigenically monotypic virus, nucleotide sequence analysis of the hemagglutinin and nucleoprotein genes has permitted the differentiation of a number of genotypes. In contrast, the fusion (F) protein is highly conserved; only three amino acid changes have been reported over a 40-year period. We have isolated a measles virus strain which did not react with an anti-F monoclonal antibody (MAb) which we had previously shown to be directed against a dominant antigenic site. This virus strain, Lys-1, had seven amino acid changes compared with the Edmonston strain. We have shown that a single amino acid at position 73 is responsible for its nonreactivity with the anti-F MAb. With the same MAb, antibody-resistant mutants were prepared from the vaccine strain. A single amino acid change at position 73 (R-->W) was observed. The possibility of selecting measles virus variants in vaccinated populations is discussed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9847389      PMCID: PMC103890     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Contribution of measles virus fusion protein in protective immunity: anti-F monoclonal antibodies neutralize virus infectivity and protect mice against challenge.

Authors:  E Malvoisin; F Wild
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

2.  Cloning and expression of foreign genes in vaccinia virus, using a host range selection system.

Authors:  M E Perkus; K Limbach; E Paoletti
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

3.  Fusion glycoprotein of measles virus: nucleotide sequence of the gene and comparison with other paramyxoviruses.

Authors:  R Buckland; C Gerald; R Barker; T F Wild
Journal:  J Gen Virol       Date:  1987-06       Impact factor: 3.891

4.  Determination of the number of nonoverlapping antigenic areas on Hong Kong (H3N2) influenza virus hemagglutinin with monoclonal antibodies and the selection of variants with potential epidemiological significance.

Authors:  R G Webster; W G Laver
Journal:  Virology       Date:  1980-07-15       Impact factor: 3.616

5.  Subclinical measles infection in vaccinated seropositive individuals in arctic Greenland.

Authors:  I R Pedersen; C H Mordhorst; G Glikmann; H von Magnus
Journal:  Vaccine       Date:  1989-08       Impact factor: 3.641

6.  Naturally occurring human parainfluenza type 3 viruses exhibit divergence in amino acid sequence of their fusion protein neutralization epitopes and cleavage sites.

Authors:  K V Coelingh; C C Winter
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

7.  Protective role of human antibody to the fusion protein of measles virus.

Authors:  T A Sato; T Kohama; A Sugiura
Journal:  Microbiol Immunol       Date:  1989       Impact factor: 1.955

8.  Extreme heterogeneity in populations of vesicular stomatitis virus.

Authors:  D A Steinhauer; J C de la Torre; E Meier; J J Holland
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

9.  Protection of mice from fatal measles encephalitis by vaccination with vaccinia virus recombinants encoding either the hemagglutinin or the fusion protein.

Authors:  R Drillien; D Spehner; A Kirn; P Giraudon; R Buckland; F Wild; J P Lecocq
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

10.  Monoclonal antibodies against measles virus.

Authors:  P Giraudon; T F Wild
Journal:  J Gen Virol       Date:  1981-06       Impact factor: 3.891

View more
  7 in total

1.  A recombinant measles vaccine virus expressing wild-type glycoproteins: consequences for viral spread and cell tropism.

Authors:  I C Johnston; V ter Meulen; J Schneider-Schaulies; S Schneider-Schaulies
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Mutational Analysis of Measles Virus Suggests Constraints on Antigenic Variation of the Glycoproteins.

Authors:  Benjamin O Fulton; David Sachs; Shannon M Beaty; Sohui T Won; Benhur Lee; Peter Palese; Nicholas S Heaton
Journal:  Cell Rep       Date:  2015-05-21       Impact factor: 9.423

3.  Comparative analysis of titers of antibody against measles virus in sera of vaccinated and naturally infected Japanese individuals of different age groups.

Authors:  Masae Itoh; Yoshinobu Okuno; Hak Hotta
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

4.  Genotyping measles virus by real-time amplification refractory mutation system PCR represents a rapid approach for measles outbreak investigations.

Authors:  Diane Waku-Kouomou; Amal Alla; Bariza Blanquier; Damien Jeantet; Hayat Caidi; Ahmed Rguig; François Freymuth; Fabian T Wild
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

5.  Molecular Features of the Measles Virus Viral Fusion Complex That Favor Infection and Spread in the Brain.

Authors:  Cyrille Mathieu; Francesca T Bovier; Marion Ferren; Nicole A P Lieberman; Camilla Predella; Alexandre Lalande; Vikas Peddu; Michelle J Lin; Amin Addetia; Achchhe Patel; Victor Outlaw; Barbara Corneo; N Valerio Dorrello; Thomas Briese; Diana Hardie; Branka Horvat; Anne Moscona; Alexander L Greninger; Matteo Porotto
Journal:  mBio       Date:  2021-06-01       Impact factor: 7.867

6.  Interpreting changes in measles genotype: the contribution of chance, migration and vaccine coverage.

Authors:  Shuko Nojiri; Emilia Vynnycky; Nigel Gay
Journal:  BMC Infect Dis       Date:  2008-04-11       Impact factor: 3.090

7.  Measles Virus: Identification in the M Protein Primary Sequence of a Potential Molecular Marker for Subacute Sclerosing Panencephalitis.

Authors:  Hasan Kweder; Michelle Ainouze; Joanna Brunel; Denis Gerlier; Evelyne Manet; Robin Buckland
Journal:  Adv Virol       Date:  2015-10-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.